annual EBIT:
-$466.57M-$244.03M(-109.66%)Summary
- As of today (June 29, 2025), CRSP annual earnings before interest & taxes is -$466.57 million, with the most recent change of -$244.03 million (-109.66%) on December 31, 2024.
- During the last 3 years, CRSP annual EBIT has fallen by -$840.09 million (-224.91%).
- CRSP annual EBIT is now -224.91% below its all-time high of $373.53 million, reached on December 31, 2021.
Performance
CRSP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$148.42M-$83.84M(-129.80%)Summary
- As of today (June 29, 2025), CRSP quarterly earnings before interest & taxes is -$148.42 million, with the most recent change of -$83.84 million (-129.80%) on March 31, 2025.
- Over the past year, CRSP quarterly EBIT has dropped by -$7.84 million (-5.57%).
- CRSP quarterly EBIT is now -119.46% below its all-time high of $762.62 million, reached on June 30, 2021.
Performance
CRSP quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$474.40M-$7.84M(-1.68%)Summary
- As of today (June 29, 2025), CRSP TTM earnings before interest & taxes is -$474.40 million, with the most recent change of -$7.84 million (-1.68%) on March 31, 2025.
- Over the past year, CRSP TTM EBIT has dropped by -$175.76 million (-58.86%).
- CRSP TTM EBIT is now -205.91% below its all-time high of $447.92 million, reached on June 30, 2021.
Performance
CRSP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRSP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -109.7% | -5.6% | -58.9% |
| 3 y3 years | -224.9% | +15.7% | -252.0% |
| 5 y5 years | -1098.2% | -101.7% | -2298.7% |
CRSP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -224.9% | +30.7% | -313.3% | +19.0% | -252.0% | +31.0% |
| 5 y | 5-year | -224.9% | +30.7% | -119.5% | +19.0% | -205.9% | +31.0% |
| alltime | all time | -224.9% | +30.7% | -119.5% | +19.0% | -205.9% | +31.0% |
CRSP EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$148.42M(+129.8%) | -$474.40M(+1.7%) |
| Dec 2024 | -$466.57M(+109.7%) | -$64.59M(-41.4%) | -$466.56M(+40.4%) |
| Sep 2024 | - | -$110.13M(-27.2%) | -$332.39M(-6.3%) |
| Jun 2024 | - | -$151.26M(+7.6%) | -$354.68M(+18.8%) |
| Mar 2024 | - | -$140.59M(-302.0%) | -$298.64M(+34.2%) |
| Dec 2023 | -$222.54M(-66.9%) | $69.58M(-152.6%) | -$222.54M(-47.5%) |
| Sep 2023 | - | -$132.41M(+39.1%) | -$423.66M(-10.6%) |
| Jun 2023 | - | -$95.22M(+47.7%) | -$473.64M(-15.7%) |
| Mar 2023 | - | -$64.49M(-51.0%) | -$561.68M(-16.6%) |
| Dec 2022 | -$673.16M(-280.2%) | -$131.54M(-27.9%) | -$673.16M(-2.1%) |
| Sep 2022 | - | -$182.39M(-0.5%) | -$687.32M(+8.4%) |
| Jun 2022 | - | -$183.26M(+4.1%) | -$633.78M(-303.1%) |
| Mar 2022 | - | -$175.97M(+20.8%) | $312.10M(-16.4%) |
| Dec 2021 | $373.53M(-205.4%) | -$145.70M(+13.1%) | $373.53M(-9.2%) |
| Sep 2021 | - | -$128.85M(-116.9%) | $411.46M(-8.1%) |
| Jun 2021 | - | $762.62M(-765.8%) | $447.92M(-213.3%) |
| Mar 2021 | - | -$114.54M(+6.3%) | -$395.39M(+11.6%) |
| Dec 2020 | -$354.44M | -$107.76M(+16.6%) | -$354.44M(+50.4%) |
| Sep 2020 | - | -$92.40M(+14.5%) | -$235.69M(+5608.2%) |
| Jun 2020 | - | -$80.69M(+9.7%) | -$4.13M(-119.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$73.59M(-770.0%) | $21.58M(-53.8%) |
| Dec 2019 | $46.74M(-129.4%) | $10.98M(-92.1%) | $46.74M(-593.5%) |
| Sep 2019 | - | $139.16M(-353.1%) | -$9.47M(-95.2%) |
| Jun 2019 | - | -$54.98M(+13.5%) | -$198.07M(+9.8%) |
| Mar 2019 | - | -$48.42M(+7.1%) | -$180.37M(+13.5%) |
| Dec 2018 | -$158.94M(+145.9%) | -$45.23M(-8.5%) | -$158.94M(+41.0%) |
| Sep 2018 | - | -$49.43M(+32.6%) | -$112.74M(+29.8%) |
| Jun 2018 | - | -$37.29M(+38.1%) | -$86.88M(+22.5%) |
| Mar 2018 | - | -$27.00M(-2877.5%) | -$70.90M(+9.7%) |
| Dec 2017 | -$64.65M(+340.7%) | $972.00K(-104.1%) | -$64.65M(+34.3%) |
| Sep 2017 | - | -$23.57M(+10.6%) | -$48.12M(+22.6%) |
| Jun 2017 | - | -$21.31M(+2.7%) | -$39.24M(+11.8%) |
| Mar 2017 | - | -$20.74M(-218.6%) | -$35.10M(+139.3%) |
| Dec 2016 | -$14.67M(-43.0%) | $17.50M(-219.1%) | -$14.67M(-66.9%) |
| Sep 2016 | - | -$14.69M(-14.4%) | -$44.28M(+23.7%) |
| Jun 2016 | - | -$17.16M(+5331.6%) | -$35.79M(+92.2%) |
| Mar 2016 | - | -$316.00K(-97.4%) | -$18.63M(+1.7%) |
| Dec 2015 | -$25.71M(+274.7%) | -$12.12M(+95.7%) | -$18.31M(+195.7%) |
| Sep 2015 | - | -$6.19M | -$6.19M |
| Dec 2014 | -$6.86M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual earnings before interest & taxes?
- What is the all time high annual EBIT for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual EBIT year-on-year change?
- What is CRISPR Therapeutics AG quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly EBIT year-on-year change?
- What is CRISPR Therapeutics AG TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM EBIT year-on-year change?
What is CRISPR Therapeutics AG annual earnings before interest & taxes?
The current annual EBIT of CRSP is -$466.57M
What is the all time high annual EBIT for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual earnings before interest & taxes is $373.53M
What is CRISPR Therapeutics AG annual EBIT year-on-year change?
Over the past year, CRSP annual earnings before interest & taxes has changed by -$244.03M (-109.66%)
What is CRISPR Therapeutics AG quarterly earnings before interest & taxes?
The current quarterly EBIT of CRSP is -$148.42M
What is the all time high quarterly EBIT for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly earnings before interest & taxes is $762.62M
What is CRISPR Therapeutics AG quarterly EBIT year-on-year change?
Over the past year, CRSP quarterly earnings before interest & taxes has changed by -$7.84M (-5.57%)
What is CRISPR Therapeutics AG TTM earnings before interest & taxes?
The current TTM EBIT of CRSP is -$474.40M
What is the all time high TTM EBIT for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM earnings before interest & taxes is $447.92M
What is CRISPR Therapeutics AG TTM EBIT year-on-year change?
Over the past year, CRSP TTM earnings before interest & taxes has changed by -$175.76M (-58.86%)